Navigation Links
Former GE, Kodak and SGS Executive Dan Kerpelman to Join Bio-Optronics as President and CEO
Date:5/1/2008

ROCHESTER, N.Y., May 1 /PRNewswire/ -- Bio-Optronics announced Thursday that a majority of the company's shares had been acquired by Dan Kerpelman, who will be joining the healthcare workflow technology company as President and CEO.

Kerpelman brings over thirty years of executive experience to Bio-Optronics, a healthcare workflow technology provider with headquarters in Rochester, NY. The company's product portfolio includes innovative workflow management and optimization solutions for hospitals, specialty medical practices and clinical researchers. Kerpelman plans to lead the company through an expansion of its current product offerings and into new markets both within the U.S. and Europe.

Kerpelman explained the decision to join Bio-Optronics by saying, "I've been seeking to leverage my multinational healthcare technology experience in a more entrepreneurial environment. I am so pleased and proud to partner with Mike Kamish and his team. Their innovative products and services have created solutions to some of healthcare's most challenging problems, and we are all enthusiastic to work together to take Bio-Optronics to new heights."

The company's former President and CTO, Mike Kamish, will remain in the role of Vice President and CTO. Kamish said, "We are delighted with Dan's commitment to Bio-Optronics. His experience in the field of healthcare technology and his management experience at GE Healthcare, Kodak Health Imaging, and SGS will be a tremendous asset to the future growth of the company."

Later this month, the company will introduce a new corporate logo, product branding scheme and website, emphasizing its focus on innovative healthcare workflow technology.

About Dan Kerpelman

Dan Kerpelman has thirty years of professional experience, mostly in healthcare technology. He was recently CEO of the Societe Generale de Surveillance in Geneva, Switzerland where he led a $3.5B services company of 46,000 employees, including a life science division engaged in clinical research support. Prior to SGS, he was President of the $2.7B Kodak Health Imaging Group, and Senior Vice-President of the Eastman Kodak Company in Rochester, NY. Dan joined Kodak after seventeen years with GE Healthcare, most recently as GM of the Global X-Ray business, based in Paris, France.

Dan is a member of the boards of the University of Rochester Medical Center, XCounter AB, eHealth Global Technologies, Inc. and VirtualScopics, Inc. He has an MBA from Northwestern University, an MS in Computer Engineering from Rensselaer Polytechnic Institute, and a BS in Computer Science from the University of Maryland.

About Bio-Optronics

Bio-Optronics, The Experts in Healthcare Workflow Technology, is a privately-held corporation founded by Mike Kamish in Rochester, NY in 1985. The company's Dynamic Hospital division provides hospital point-of-care and workflow optimization solutions. The company's Clinical Conductor division provides workflow management solutions for clinical researchers. To learn more, visit http://www.bio-optronics.com.

Contact: Rebecca M. Guerra, VP and Marketing Director.

Tel. 877-279-8377, ext. 201. Email. rguerra@bio-optronics.com.


'/>"/>
SOURCE Bio-Optronics
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
2. Former Banc of America Securities Analyst David Maris Comments on Decision by Biovail to Drop Its Claims Against Him; Denies That He is Cooperating With Biovail
3. David Barker, Former Illumina CSO, Joins GenVaults Scientific Advisory Board
4. Former Pfizer Director of Inflammation Molecular Sciences to Spearhead Velcura Therapeutics Inflammatory Disease Initiatives
5. Kendle Appoints Former MHRA Head of Biologics as Principal Regulatory Affairs Consultant
6. Seahorse Bioscience Appoints Former Molecular Devices Executive Dr. Joseph D. Keegan to Board of Directors
7. Former Patent Office Solicitor and Judge Joins Rothwell Figg
8. Leading DHA Expert and Former NIH Researcher, Dr. Norman Salem, Jr., to Join Martek as Chief Scientific Officer
9. Molecular Diagnostics Leader AdvanDx Taps Former Dako Executive Vice President to Lead Global Sales and Marketing Expansion
10. Former Manchester City Lord Mayor Has Hope Restored at New Beike Stem Cell Facility
11. John E. Leonard, Ph.D., Former Biogen Idec Antibody Development Executive, Joins the Scientific Advisory Board of Vaccinex, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ANN ARBOR, Mich. , Dec. 7, 2016 ... breakthrough immune modulatory medicines, announced today the initiation of ... therapeutic candidate, LYC-30937- E nteric C oated, in ... disease that is estimated to affect as many as ... , with approximately 1.5 - 3 million cases being ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... digital pathology, announced today a new service to enable rapid migration of large ... upload has remained one of the factors limiting adoption of digital pathology. Proscia’s ...
(Date:12/7/2016)... Woods Hole, Massachusetts (PRWEB) , ... December 07, 2016 , ... Kara Dwyer Dodge grew ... 1966, Richard Dwyer, a third-generation fisherman in Scituate, Mass., found a sea turtle entangled in ... to shore, where the turtle became a minor sensation because no one could remember ever ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... privately-held contract pharmaceutical development and manufacturing organisation, today announced the formation ... combining a leading CRO and the industry’s only Contract Commercial Organization (CCO). ...
Breaking Biology Technology:
(Date:11/19/2016)... , Nov. 18, 2016 Securus Technologies, a ... for public safety, investigation, corrections and monitoring, announced today ... competitor, ICSolutions, to have an independent technology judge determine ... most modern high tech/sophisticated telephone calling platform, and the ... that they do most of what we do – ...
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, Inc. ... therapeutics focused on the gut microbiome, today announced ... 25,000,000 shares of its common stock and warrants ... at a price to the public of $1.00 ... Synthetic Biologics from the offering, excluding the proceeds, ...
(Date:6/27/2016)... Research and Markets has announced the addition of the ... The report forecasts the biometrics ... a CAGR of 12.28% during the period 2016-2020. ... with inputs from industry experts. The report covers the market landscape ... includes a discussion of the key vendors operating in this market. ...
Breaking Biology News(10 mins):